Implementing high-quality cancer survivorship care in primary care: future directions for policy and research.

IF 7.2 1区 医学 Q1 ONCOLOGY
Julien A M Vos, Nicole L Stout, Larissa Nekhlyudov
{"title":"Implementing high-quality cancer survivorship care in primary care: future directions for policy and research.","authors":"Julien A M Vos, Nicole L Stout, Larissa Nekhlyudov","doi":"10.1093/jnci/djaf259","DOIUrl":null,"url":null,"abstract":"<p><p>Nearly 20 million people in the U.S. are living with and beyond a cancer diagnosis, many of whom survive for decades after treatment. As this population continues to grow and age, primary care (PC) plays an increasingly important role in managing long-term and late effects of treatment. However, efforts to improve survivorship care (SC) delivery in PC have only recently gained attention. With more survivors relying on their primary care clinicians (PCCs), there is a clear need to strengthen the implementation of high-quality SC in PC settings. In this commentary, we explore how high-quality SC can be implemented in PC, using the implementation plan outlined in the National Academies of Sciences, Engineering, and Medicine (NASEM) report Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. We describe the evidence on PCCs' roles across the cancer care continuum and map the evidence to the NASEM report's five implementation objectives: payment, access, workforce, digital health, and accountability. Through this work, we identify future directions for policy and research to ensure that PC can serve as a \"common good\" for all cancer survivors.</p>","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Journal of the National Cancer Institute","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jnci/djaf259","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Nearly 20 million people in the U.S. are living with and beyond a cancer diagnosis, many of whom survive for decades after treatment. As this population continues to grow and age, primary care (PC) plays an increasingly important role in managing long-term and late effects of treatment. However, efforts to improve survivorship care (SC) delivery in PC have only recently gained attention. With more survivors relying on their primary care clinicians (PCCs), there is a clear need to strengthen the implementation of high-quality SC in PC settings. In this commentary, we explore how high-quality SC can be implemented in PC, using the implementation plan outlined in the National Academies of Sciences, Engineering, and Medicine (NASEM) report Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care. We describe the evidence on PCCs' roles across the cancer care continuum and map the evidence to the NASEM report's five implementation objectives: payment, access, workforce, digital health, and accountability. Through this work, we identify future directions for policy and research to ensure that PC can serve as a "common good" for all cancer survivors.

在初级保健中实施高质量的癌症生存护理:政策和研究的未来方向。
美国有近2000万人患有癌症,其中许多人在接受治疗后存活了几十年。随着这一人口的持续增长和老龄化,初级保健(PC)在管理长期和晚期治疗效果方面发挥着越来越重要的作用。然而,努力提高生存护理(SC)的交付在PC最近才得到关注。随着越来越多的幸存者依赖于他们的初级保健临床医生(PCCs),显然需要在PC设置中加强高质量SC的实施。在这篇评论中,我们探讨了如何在PC中实施高质量的SC,使用美国国家科学院、工程院和医学院(NASEM)报告中概述的实施计划实施高质量的初级保健:重建卫生保健的基础。我们描述了PCCs在癌症治疗连续体中的作用的证据,并将证据映射到NASEM报告的五个实施目标:支付、获取、劳动力、数字健康和问责制。通过这项工作,我们确定了政策和研究的未来方向,以确保PC可以作为所有癌症幸存者的“共同利益”。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
17.00
自引率
2.90%
发文量
203
审稿时长
4-8 weeks
期刊介绍: The Journal of the National Cancer Institute is a reputable publication that undergoes a peer-review process. It is available in both print (ISSN: 0027-8874) and online (ISSN: 1460-2105) formats, with 12 issues released annually. The journal's primary aim is to disseminate innovative and important discoveries in the field of cancer research, with specific emphasis on clinical, epidemiologic, behavioral, and health outcomes studies. Authors are encouraged to submit reviews, minireviews, and commentaries. The journal ensures that submitted manuscripts undergo a rigorous and expedited review to publish scientifically and medically significant findings in a timely manner.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信